Can intestinal mucosal cytokine levels be used as markers to differentiate and assess the severity of ulcerative colitis and Crohns disease patients
Weissman, S.; Lam, S.; Bailey, B.; Greenberg, R.; Blumstein, M.; Bank, S.
Gastroenterology 108(4 Suppl): A939
1995
ISSN/ISBN: 0016-5085
Accession: 030396947
PDF emailed within 1 workday: $29.90
Related References
Dohil, R.; Israel, D.M.; Lam, V.; Krystal, G. 1996: Intestinal mucosal interleukin-6 levels in children with Crohns disease , ulcerative colitis and in non-inflammatory controls-preliminary study Gastroenterology 110(4 Suppl): A897Bitsanis, D.C.; Heuschkel, R.; Ghebremeskel, K.; Walker Smith, J.; Crawford, M.A. 2001: Arachidonate and docosahexaenoate could be biochemical markers to differentiate between Crohns disease and ulcerative colitis Biochemical Society Transactions 29(1): A23
Radford Smith, G.; Mcgowan, I.; Keshav, S.; Jewell, D.P. 1993: Investigation of mucosal cytokine mRNA transcripts in patients with ulcerative colitis and Crohns disease Gastroenterology 104(4 Suppl): A767
Mullin, G.E.; Harris, M.L.; Bayless, T.M.; James, S.P. 1991: Increased il 2 messenger rna in the intestinal mucosal lesions of crohns disease but not ulcerative colitis Gastroenterology 100(5 Part 2): A602
Mullin, G.E.; Maycon, Z.; Schmidt, A.; Vezza, F.; Sampat, A.; Katz, S.; Weissman, G.; Goldman, I.; Bronzo, R. 1993: Elevated intestinal mucosal interleukin-5 mRNA distinguishes ulcerative colitis from Crohns disease Pediatric Research 33(4 Part 2): 106A
Van Damme, Nancy; Baeten, Dominique; De Keyser, Filip; Demetter, Pieter; Elewaut, Dirk; Cuvelier, Claude; Mielants, Herman; Verbruggen, Gust; Veys, Eric M.; De Vos, Martine 2000: Different cytokine profiles in peripheral blood and mucosal T lymphocytes of normal controls, Crohns disease and ulcerative colitis patients Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1374
Linskens, R.K.; Mallant-Hent, R.C.; Groothuismink, Z.M.Anthonie.; Bakker-Jonges, L.E.; van de Merwe, J.P.; Hooijkaas, H.; von Blomberg, B.Mary.E.; Meuwissen, S.G.M. 2002: Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods European Journal of Gastroenterology and Hepatology 14(9): 1013-1018
Ponchon, T.; Jourdan, G.; Descos, L.; Chayvialle, J.A. 1984: Mucosal concentrations of vasoactive intestinal peptide somatostatin and substance p in crohns disease and ulcerative colitis Gastroenterology 86(5 Part 2): 1211
Plevy, S.E.; Targan, S.R.; Andus, T.; Toyoda, H. 1993: Differentiation of Crohns disease from ulcerative colitis mucosal inflammation by levels of TNF-alpha mRNA Gastroenterology 104(4 Suppl): A764
Jaszewski, R.; Weinstock, J.V.; Tolia, V.; Ehrinpreis, M.; Bodzin, J.; Peleman, R.; Korlipara, R. 1989: Colonic mucosal levels of angiotensin i ai and ii aii distinguish crohns colitis from ulcerative colitis Gastroenterology 96(5 Part 2): A238
Reimund, J.M.; Wittersheim, C.; Dumont, S.; Muller, C.D.; Baumann, R.; Poindron, P.; Duclos, B. 1996: Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease Journal of Clinical Immunology 16(3): 144-150
Funakoshi, K.; Sugimura, K.; Anezaki, K.; Bannai, H.; Ishizuka, K.; Asakura, H. 1998: Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis Digestion 59(1): 73-78
Lam, S.; Weissman, S.; Bailey, B.; Bank, S. 1995: Elevated basal intestinal mucosal cytokine levels in first degree relatives of patients with Crohns disease Gastroenterology 108(4 Suppl): A856
Geboes, K. 2008: What histologic features best differentiate Crohns disease from ulcerative colitis? Inflammatory Bowel Diseases 14(Suppl): S168-S169
Mullin, G.E.; Cerchia, R.; Werner, C.; Bui, T.; Reddy, G.M.; Procaccino, J.; Mckinley, M.J. 1998: Mucosal IL-18 mRNA is increased in Crohns disease but not ulcerative colitis Gastroenterology 114(4 Part 2): A1046
Fan, I.; Moayyedi, P.; Lewis, F.A.; Cawkwell, L.; Quirke, P. 1996: A PCR study to assess the involvement of viruses in Crohns disease and ulcerative colitis Journal of Pathology 178(Suppl): 17A
Robinson, M.G.; Dorrough, C.A. 1988: Metamorphosis of mucosal ulcerative colitis to crohn's disease with olsalazine and other 5 asa analogs Gastroenterology 94(5 Part 2): A380
Robinson, M.G.; Dorrough, C. 1987: Metamorphosis of mucosal ulcerative colitis to crohn's disease with azodisalicylate sodium American Journal of Gastroenterology 82(9): 953
Tran, D.H.-N.; Wang, J.; Ha, C.; Ho, W.; Mattai, S.A.; Oikonomopoulos, A.; Weiss, G.; Lacey, P.; Cheng, M.; Shieh, C.; Mussatto, C.C.; Ho, S.; Hommes, D.; Koon, H.W. 2017: Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease Bmc Gastroenterology 17(1): 63
Kruidenier, L.; Kuiper, G.; Van Duijn, W.; Mieremet Ooms, M.A.C.; Van Hogezand, R.A.; Lamers, C.B.H.W.; Verspaget, H.W. 1999: Diverging pathways of mucosal oxidative damage in Crohns disease and ulcerative colitis Immunology Letters 69(1): 158-159